154 related articles for article (PubMed ID: 23604819)
1. Synthesis, cytotoxicity and QSAR study of N-tosyl-1,2,3,4-tetrahydroisoquinoline derivatives.
Pingaew R; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Arch Pharm Res; 2013 Sep; 36(9):1066-77. PubMed ID: 23604819
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of a series of 6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-2-substituted tetrahydroisoquinoline derivatives.
Zou ZH; Lan XB; Tang CL; Zhu XY; Liu BM; Qian H; Huang WL; Li YM
Med Chem; 2012 Jul; 8(4):711-6. PubMed ID: 22530912
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.
Prachayasittikul V; Pingaew R; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Sep; 84():247-63. PubMed ID: 25019480
[TBL] [Abstract][Full Text] [Related]
5. Anticancer activities of some newly synthesized pyrazole and pyrimidine derivatives.
Mohamed AM; El-Sayed WA; Alsharari MA; Al-Qalawi HR; Germoush MO
Arch Pharm Res; 2013 Sep; 36(9):1055-65. PubMed ID: 23737106
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
Zou ZH; Lan XB; Qian H; Huang WL; Li YM
Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
[TBL] [Abstract][Full Text] [Related]
7. Estimation of relationship between descriptors and cytotoxicity of newly synthesized 1,2,3,4-tetrahydroisoquinoline derivatives.
Ishihara M; Hatano H; Takekawa F; Kawase M; Sakagami H
Anticancer Res; 2009 Oct; 29(10):4077-82. PubMed ID: 19846954
[TBL] [Abstract][Full Text] [Related]
8. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity of (-)-renieramycin G analogs.
Liu W; Dong W; Liao X; Yan Z; Guan B; Wang N; Liu Z
Bioorg Med Chem Lett; 2011 Mar; 21(5):1419-21. PubMed ID: 21295980
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and inhibition of cancer cell proliferation of (1,3')-bis-tetrahydroisoquinolines and piperazine systems.
Aubry S; Pellet-Rostaing S; Fournier Dit Chabert J; Ducki S; Lemaire M
Bioorg Med Chem Lett; 2007 May; 17(9):2598-602. PubMed ID: 17317166
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.
Zhang X; Zhang J; Zhang L; Feng J; Xu Y; Yuan Y; Fang H; Xu W
Bioorg Med Chem; 2011 Oct; 19(20):6015-25. PubMed ID: 21911297
[TBL] [Abstract][Full Text] [Related]
12. 11a-N-tosyl-5-carbapterocarpans: Synthesis, antineoplastic evaluation and in silico prediction of ADMETox properties.
Mendes JA; Salustiano EJ; Pires CS; Oliveira T; Barcellos JCF; Cifuentes JMC; Costa PRR; Rennó MN; Buarque CD
Bioorg Chem; 2018 Oct; 80():585-590. PubMed ID: 30036814
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxicity of novel 2,2'-bis- and 2,2',2″-tris-indolylmethanes-based bengacarboline analogs.
Pingaew R; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Arch Pharm Res; 2012 Jun; 35(6):949-54. PubMed ID: 22870803
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 3-Methylidene-1-tosyl-2,3-dihydroquinolin-4(1H)-ones as Potent Cytotoxic Agents.
Koszuk J; Bartosik T; Wojciechowski J; Wolf WM; Janecka A; Drogosz J; Długosz A; Krajewska U; Mirowski M; Janecki T
Chem Biodivers; 2018 Sep; 15(9):e1800242. PubMed ID: 29935105
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship (QSAR) analysis of tumor-specificity of 1,2,3,4-tetrahydroisoquinoline derivatives.
Uesawa Y; Mohri K; Kawase M; Ishihara M; Sakagami H
Anticancer Res; 2011 Dec; 31(12):4231-8. PubMed ID: 22199286
[TBL] [Abstract][Full Text] [Related]
16. Identification of a series of tetrahydroisoquinoline derivatives as potential therapeutic agents for breast cancer.
Lin HR; Safo MK; Abraham DJ
Bioorg Med Chem Lett; 2007 May; 17(9):2581-9. PubMed ID: 17337183
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G.
Lane JW; Estevez A; Mortara K; Callan O; Spencer JR; Williams RM
Bioorg Med Chem Lett; 2006 Jun; 16(12):3180-3. PubMed ID: 16632360
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antitubulin, and antiproliferative SAR of C3/C1-substituted tetrahydroisoquinolines.
Dohle W; Leese MP; Jourdan FL; Major MR; Bai R; Hamel E; Ferrandis E; Kasprzyk PG; Fiore A; Newman SP; Purohit A; Potter BV
ChemMedChem; 2014 Feb; 9(2):350-70. PubMed ID: 24436228
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric Synthesis and Cytotoxicity Evaluation of Right-Half Models of Antitumor Renieramycin Marine Natural Products.
Matsubara T; Yokoya M; Sirimangkalakitti N; Saito N
Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30577460
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of cis-dichloroplatinum(II) complexes of 1-(2-aminophenyl)-1,2,3,4-tetrahydroisoquinolines.
Kuo CY; Wu MJ; Kuo YH
Eur J Med Chem; 2006 Aug; 41(8):940-9. PubMed ID: 16647164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
